Sigrid Kufaas Brækkan
Job description
Professor, Tromboseforskning (TREC)
Christopher,
Julia,
Vania Maris,
Kristian,
Sigrid Kufaas,
Pilar
et al.:
Plasma miR-145-5p Levels and Risk of Future Cancer—Results from the HUNT Study
International Journal of Molecular Sciences 2025 DOI
Carl Arne Løchen,
Kristian,
Maiken Elvestad,
John Bjarne,
Sigrid Kufaas
:
Body height and risk of venous thromboembolism in men vs women
Journal of Thrombosis and Haemostasis 2025 DOI
Christabel Esi,
Solveig Marie,
Omri,
Kristian Dalsbø,
Sigrid Kufaas,
Steven P.
et al.:
Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: HUNT
Arteriosclerosis, Thrombosis and Vascular Biology 2025 DOI
Nikolai Hagensen,
Camilla,
Fridtjof Balteskard,
Nick van,
Kristian,
Sigrid Kufaas
et al.:
Mortality risk after cancer-related venous thromboembolism has decreased over the last three decades: the HUNT and Tromsø studies
Haematologica 2025 DOI
Oda,
John Bjarne,
Sigrid Kufaas
:
Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromso Study
Thrombosis and Haemostasis 2025 DOI
Erin Mathiesen,
Maja-Lisa,
Ellisiv B.,
Kristian,
Sigrid Kufaas,
John Bjarne
:
Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of ischemic stroke
Journal of Thrombosis and Haemostasis 2025 DOI
Vania Maris,
Omri,
Kristian Dalsbø,
Kristian,
Sigrid Kufaas,
John Bjarne
:
High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study
Carl-Arne,
Line Holtet,
Kristian,
Maiken Elvestad,
John Bjarne,
Sigrid Kufaas
:
Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women
Zygimantas,
Camilla Tøvik,
Andreas,
Heidi Hassel,
Aleksandra Grdinic,
Sigrid Kufaas
et al.:
Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
Luuk J.J.,
Sigrid Kufaas,
Judith P.L.,
Suzanne C.,
John Bjarne,
Vania Maris
:
The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study
Christopher,
Vårin Eiriksdatter,
Øyvind,
Thor,
Gholamreza Jafari,
Sigrid Kufaas
et al.:
Plasma microRNA-145-5p as a diagnostic biomarker for acute deep vein thrombosis
Research and Practice in Thrombosis and Haemostasis (RPTH) 2024 DOI
Birgitte Gladsø,
Joakim Knutsen,
Vania Maris,
Maja-Lisa,
Inger,
Ellisiv B.
et al.:
Joint effect of ischemic stroke and obesity on the risk of venous thromboembolism: the Tromsø Study
Sigrid Kufaas,
Asbjørn Lund,
Therese Haugdahl,
Weihong,
Kristian Dalsbø,
Vania Maris
et al.:
The Plasma Proteome and Risk of Future Venous Thromboembolism—Results from the HUNT Study
Oda,
Vania Maris,
John Bjarne,
Sigrid Kufaas
:
Hand grip strength in venous thromboembolism: risk of recurrence and mortality
Monique J.T.,
Rayna J.S.,
Sigrid Kufaas,
Marianne T.,
Jens,
Hanne
et al.:
Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
Maria A. De,
Harry R.,
Marc,
Alexander T.,
John Bjarne,
Karin A. H.
et al.:
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
Ellen-Sofie,
Magnus,
Pål,
Thor,
John Bjarne,
Sigrid Kufaas
et al.:
Combined effect of high factor VIII levels and high mean platelet volume on the risk of future incident venous thromboembolism
Dana,
Sigrid Kufaas,
John Bjarne,
Vania Maris
:
Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study
Samantha,
Thor,
John Bjarne,
Omri,
Sigrid Kufaas
:
Plasma levels of P-selectin and future risk of incident venous thromboembolism
Fridtjof Balteskard,
Camilla Tøvik,
Heidi Hassel,
John Bjarne,
Waleed,
Sigrid Kufaas
:
Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
Tobias,
Birgitte Gladsø,
Sigrid Kufaas,
John Bjarne,
Vania Maris
:
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromso Study
Steven P.,
Omri,
Kristian Dalsbø,
Tatianna M.,
Sigrid Kufaas,
Vania Maris
et al.:
High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism
Steven P.,
Tomohiro,
Jun,
Pansakorn,
Zsofia,
Young J.
et al.:
C1 inhibitor deficiency enhances contact pathway–mediated activation of coagulation and venous thrombosis
Camilla Tøvik,
Sigrid Kufaas,
Eli,
Heidi Hassel,
Eirik,
Waleed
et al.:
Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
Camilla Tøvik,
Mazdak,
Elise,
Heidi Hassel,
Eirik,
Waleed
et al.:
Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
Espen Waage,
Line Holtet,
Søren Beck,
Nadezhda,
Annika Elisabet,
Thor
et al.:
Complement factors B, D, C3bBbP and risk of future venous thromboembolism
loannis T.,
Stefano,
Lukas,
Sigrid Kufaas,
Jean M.,
George
et al.:
Maternal mortality related to pulmonary embolism in the United States, 2003–2020
Magnus,
Ellen-Sofie,
Thor,
Pål,
Sigrid Kufaas,
Vania Maris
et al.:
Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism
Vårin Eiriksdatter,
Birgitte Gladsø,
Vania Maris,
Ellen Elisabeth,
Sigrid Kufaas,
John Bjarne
:
Diagnostic Blood Biomarkers for Acute Pulmonary Embolism: A Systematic Review
Sigrid Kufaas,
John Bjarne
:
VTE epidemiology and challenges for VTE prevention at the population level: VTE epidemiology
Joakim Knutsen,
Birgitte Gladsø,
Vania Maris,
Maja-Lisa,
Inger,
Ellisiv B.
et al.:
Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
Omri,
line,
Nadezhda,
Casper,
Sigrid Kufaas,
Kristian Dalsbø
et al.:
Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism
Oda,
Vania Maris,
Bjørn Heine,
John Bjarne,
Sigrid Kufaas
:
Hand grip strength and risk of incident venous thromboembolism: The Tromsø study
Christabel Esi,
Omri,
Kristian Dalsbø,
Peter,
Judith K,
Sigrid Kufaas
et al.:
High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism
Elias,
Wei-Hsuan,
Stephen,
Susanna C.,
Sara,
Lu
et al.:
Genetically predicted cortisol levels and risk of venous thromboembolism
Birgitte Gladsø,
Vania Maris,
John Bjarne,
Sigrid Kufaas
:
Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
Line Holtet,
Carl-Arne,
Frits Richard,
Maiken Elvestad,
Ben Michael,
Kristian
et al.:
The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes
Camilla Tøvik,
Mazdak,
Heidi Hassel,
Eli,
Christina,
Magnus Kringstad
et al.:
The venous thrombosis registry in Østfold Hospital (TROLL registry) - design and cohort description
Lisa,
Tobias,
Sigrid Kufaas,
John Bjarne,
Vania Maris
:
Joint Effect of Multiple Prothrombotic Genotypes and Mean Platelet Volume on the Risk of Incident Venous Thromboembolism
Aniket,
Rainer,
Tsuyoshi,
Tuuli,
Shinichi,
Daniel C.
et al.:
Stroke genetics informs drug discovery and risk prediction across ancestries
Helle,
Erzsébet,
Kristina,
Sigrid Kufaas,
John Bjarne,
Henrik Toft
:
The Interaction Between Venous Thromboembolism and Socioeconomic Status on the Risk of Disability Pension
Florian,
Derek,
Jennifer A.,
Ming-Huei,
Michael G.,
Daniel I.
et al.:
Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
Tobias,
Kristian,
Pål,
Thor,
Sigrid Kufaas,
John Bjarne
et al.:
Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism
Helle,
Erzsebet,
Kristina,
Sigrid Kufaas,
John Bjarne,
Henrik Toft
:
Venous thromboembolism and risk of depression: a population-based cohort study
Magnus,
Kristian,
Ellen-Sofie,
Vania Maris,
Thor,
Pål
et al.:
Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism
Benedikte,
Olga Vikhammer,
Marianne T.,
Jens,
Søren Risom,
Suzanne C.
et al.:
Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort
Oda,
Vania Maris,
Bjørn Heine,
John Bjarne,
Sigrid Kufaas
:
Corrigendum to ‘Hand grip strength and risk of incident venous thromboembolism: The Tromsø study’: [Res Pract Thromb Haemost. 2022 Nov 4;6/7 e12833] (Research and Practice in Thrombosis and Haemostasis (2022) 6(7), (S2475037922024669), (10.1002/rth2.12833))
Research and Practice in Thrombosis and Haemostasis (RPTH) 2024 DOI
Ellen-Sofie,
Magnus,
Pål,
Thor,
John Bjarne,
Sigrid Kufaas
et al.:
Galectin-3-binding protein and future venous thromboembolism
Research and Practice in Thrombosis and Haemostasis (RPTH) 2024 DOI
Steven P.,
Linda Sundler,
Sigrid Kufaas,
Bengt,
John Bjarne,
Nigel
:
“C1-inhibitor levels and Venous Thromboembolism: Results from a Mendelian Randomization Study”: comment from Grover et al
Journal of Thrombosis and Haemostasis 2023 DOI
Steven P.,
Sigrid Kufaas,
Nigel,
John Bjarne
:
“High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism”: reply
Journal of Thrombosis and Haemostasis 2023 DOI
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
Klinisk epidemiologi og risikofaktorer for venøs tromboembolisme
Patofysiologi ved venøs tromboembolisme
Member of research group
Member of project
PREVENT
Mission-VTE
Milestone VTE
Genetics and VTE
PEPSI-VTE
Obesity-related VTE
Biomarkers of VTE risk
Diagnostic biomarkers of VTE
Cancer-associated VTE (CAT)
Sex-differences in VTE
Arterial and venous thrombosis
Life-style factors and VTE
VTE recurrence
Hypoxia-dependent proteins and VTE
Epidemiology of VTE
Risk of bleeding after VTE
CV
Utdanning/Grad
2010 PhD i Helsefag, Universitetet i Tromsø
2005 Master i Farmasi, Universitetet i Tromsø
Tidligere akademiske stillinger
2012-13 Postdoktor, Dep. of Clinical Epidemiology, Leiden University Medical Center, Nederland
2010-12 Postdoktor, Hematologisk forskningsgruppe, Universitetet i Tromsø (Helse-Nord midler)
2008-09 Universitetslektor, Avd for Farmakologi, Institutt for Farmasi, UiT
2006-08 PhD-student, Center for Atherothrombotic Research in Tromsø, UiT
2005-06 Universitetslektor, Avd for Farmakologi, Institutt for Farmasi, UiT
Publikasjoner
>185 fagfellevurderte originalartikler indeksert i PubMed. Har bidratt til mer enn 200 abstracts presentert og publisert i forbindelse med internasjonale vitenskapelige kongresser.
Andre relevante vitenskapelige verv
2021-2024: Associate Editor i Journal of Thrombosis and Haemostasis (JTH)
2016-dd: Metodologisk reviewer for Journal of Thrombosis and Haemostasis (JTH)
2016-2018: Medlem av junior advisory board for European Congress on Thrombosis and Haemostasis (ECTH)
Priser og utmerkelser
Young Investigator Award ISTH2016 (International Society of Thrombosis and Haemostasis)
Det Helsevitenskapelige Fakultets pris til yngre forsker 2017
Veiledning av PhD-studenter
Fullførte doktorgrader: Hovedveileder: 5; Biveileder: 23
Pågående doktorgrader: Hovedveileder for 5 og biveileder for 5